We preliminarily confirmed that the mitochondrial outer membrane protein FUNDC2 may promote the development of triple-negative breast cancer through the AKT/GSK3β/GLI1 signaling axis. The gene discussed is AKT1; the disease is triple-negative breast carcinoma.